Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Inge, Reynaerts"'
Autor:
Sisse R Ostrowski, Pär I. Johansson, José A Salado-Jimena, Raymond P. Goodrich, Nis A. Windeløv, Inge Reynaerts, Louise Bochsen
Publikováno v:
Transfusion. 51:344-356
BACKGROUND: Pathogen reduction technologies (PRTs) may influence the hemostatic potential of stored platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) stored in PLT additive solution (SSP+) with or without Mirasol PRT treatment
Autor:
José A Salado-Jimena, Henrik Ullum, Louise Bochsen, Sisse R. Ostrowski, Raymond P. Goodrich, Pär I. Johansson, Inge Reynaerts
Publikováno v:
Transfusion. 50:2210-2219
BACKGROUND: Pathogen reduction technologies (PRTs) may induce storage lesion in platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) in PLT additive solution (AS; SSP+) with or without Mirasol PRT (CaridianBCT Biotechnologies) wer
Autor:
Sisse R, Ostrowski, Louise, Bochsen, Nis A, Windeløv, José A, Salado-Jimena, Inge, Reynaerts, Raymond P, Goodrich, Pär I, Johansson
Publikováno v:
Transfusion. 51(2)
Pathogen reduction technologies (PRTs) may influence the hemostatic potential of stored platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) stored in PLT additive solution (SSP+) with or without Mirasol PRT treatment (CaridianBCT
Autor:
Sisse R, Ostrowski, Louise, Bochsen, José A, Salado-Jimena, Henrik, Ullum, Inge, Reynaerts, Raymond P, Goodrich, Pär I, Johansson
Publikováno v:
Transfusion. 50(10)
Pathogen reduction technologies (PRTs) may induce storage lesion in platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) in PLT additive solution (AS; SSP+) with or without Mirasol PRT (CaridianBCT Biotechnologies) were assessed b